CVE-2023-27170CWE-22path-traversal

CVE-2023-27170

High · published October 27, 2023

CVSS v3.1
7.5
EPSS
1%
Percentile
58.5
In the wild
Unconfirmed
What it is

Xpand IT Write-back manager v2.3.1 allows attackers to perform a directory traversal via modification of the siteName parameter.

The record
Technical detail
CVSS v3.1
7.5 · HIGH
Vector
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H
CVSS v4.0
Not supplied
EPSS
0.00874 · 58.5th percentile
Weakness
CWE-22 · Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')
Published
2023-10-27T03:15Z
Affected products (1)
ProductVersionsFixed in
xpand-it/write-back_managerall versions—
References (3)
https://balwurk.com/cve-2023-27170-improper-limitation-of-a-pathname-to-a-restricted-directory/ · [email protected]https://ghostline.neocities.org/CVE-2023-27170/ · [email protected]https://balwurk.com/cve-2023-27170-improper-limitation-of-a-pathname-to-a-restricted-directory/ · af854a3a-2127-422b-91ae-364da2661108
EPSS history
Timeline
  • 26 OCT 00:00Z
    Xpand IT Write-back manager v2.3.1 allows attackers to perform a directory traversal via modification of the siteName parameter
    cvelistv5